12 Oct
|
Borealis Biosciences
|
British Columbia
12 Oct
Borealis Biosciences
British Columbia
Borealis Biosciences, Inc. is seeking a Biomarker & Bioanalytical Development Lead to own the bioanalytical and biomarker strategy across the RNA therapeutics portfolio.
This senior scientist will design, build, and oversee assays measuring drug exposure, target engagement, pharmacodynamic response, and safety to support IND-enabling nonclinical and early clinical development. The role focuses on preparing for a Phase 1/2 trial, including development and transfer of regulated PK assays,
#J-18808-Ljbffr
📌 Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics (British Columbia)
🏢 Borealis Biosciences
📍 British Columbia